Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients;Liu;J Am Acad Dermatol,2017
2. Topical ruxolitinib for the treatment of alopecia universalis;Craiglow;JAMA Dermatol,2015
3. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata;Bayart;J Am Acad Dermatol,2017
4. Alopecia areata investigational assessment guidelines–part II. National Alopecia Areata Foundation;Olsen;J Am Acad Dermatol,1999
5. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis;Tosti;J Am Acad Dermatol,2003
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of topical tofacitinib in autoimmune skin disorders: An expert opinion;IP Indian Journal of Clinical and Experimental Dermatology;2024-09-15
2. Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata;Indian Dermatology Online Journal;2024-06-26
3. Efficacy of Topical Tofacitinib 2% Gel in Chronic Hand Eczema – A Case Series;Indian Dermatology Online Journal;2024-06-03
4. Novel investigational drugs for alopecia areata and future perspectives;Expert Opinion on Investigational Drugs;2024-05-03
5. Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?;The Journal of Dermatology;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3